These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Joint damage in rheumatoid arthritis progresses in remission according to the Disease Activity Score in 28 joints and is driven by residual swollen joints. Aletaha D, Smolen JS. Arthritis Rheum; 2011 Dec; 63(12):3702-11. PubMed ID: 21953215 [Abstract] [Full Text] [Related]
9. Triple therapy in early active rheumatoid arthritis: a randomized, single-blind, controlled trial comparing step-up and parallel treatment strategies. Saunders SA, Capell HA, Stirling A, Vallance R, Kincaid W, McMahon AD, Porter DR. Arthritis Rheum; 2008 May; 58(5):1310-7. PubMed ID: 18438851 [Abstract] [Full Text] [Related]
13. Absent "Window of Opportunity" in smokers with short disease duration. Data from BARFOT, a multicenter study of early rheumatoid arthritis. Söderlin MK, Bergman S, BARFOT Study Group. J Rheumatol; 2011 Oct; 38(10):2160-8. PubMed ID: 21807778 [Abstract] [Full Text] [Related]
14. Comparison of the long-term outcome for patients with rheumatoid arthritis with persistent moderate disease activity or disease remission during the first year after diagnosis: data from the ESPOIR cohort. Combe B, Logeart I, Belkacemi MC, Dadoun S, Schaeverbeke T, Daurès JP, Dougados M. Ann Rheum Dis; 2015 Apr; 74(4):724-9. PubMed ID: 24399234 [Abstract] [Full Text] [Related]